Callos Andrewinsider trades

In SEC Form 4 filings, Callos Andrew is listed as EVP, Chief Commercial Officer of Cytokinetics Inc (CYTK). In the last 90 days, Callos Andrew sold $702.4K of Cytokinetics Inc (CYTK) on the open market and bought none. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
CYTKCytokinetics Inc	EVP, Chief Commercial Officer	3	Aug 31

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-31

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CYTKCytokinetics Inc	Aug 31	Aug 31	M	10,000	$23.26	$232,600	68,555	Yes	Form 4
CYTKCytokinetics Inc	Aug 31	Aug 31	S	10,000	$70.24	Sale −$702,400	58,555	Yes	Form 4
CYTKCytokinetics Inc	Aug 31	Aug 31	M · derivative	10,000	$23.26	$232,600	not reported	Yes	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.